Back
ESC Premium Access

Multi-modality imaging in hypertrophic cardiomyopathy: intermodal discrepancies in key prognostic parameters

Session: Valvular heart disease and infective endocarditis e-posters
Topic: Imaging
Speaker: Mr T. Husselbury (London, GB)
Event: ESC Congress 2021 - The Digital Experience

Presentation

0

About the speaker

Mr Timothy Husselbury

Barts Health Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

130 more presentations in this session

Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis

Speaker: Doctor N. Ngiam (Singapore, SG)

Access
Abstract
Slides
0
Thumbnail

Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.

Speaker: Doctor Z. Cheng (Chengdu, CN)

Access
Abstract
Slides
0
Thumbnail

Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience

Speaker: Doctor S. Mahmood (Detroit, US)

Access
Abstract
Slides
0
Thumbnail

Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis

Speaker: Doctor T. Sugimoto (Tsu, JP)

Access
Abstract
Slides
0
Thumbnail

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

Speaker: Doctor V. Jimenez Franco (Madrid, ES)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Valvular heart disease and infective endocarditis e-posters

Speakers: Mr T. Husselbury, Doctor N. Ngiam, Doctor Z. Cheng, Doctor S. Mahmood, Doctor T. Sugimoto...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Pre-left ventricular hypertrophy stage in hypertrophic cardiomyopathy is it really benign?

27 August 2021

ESC Premium Access

Age-adjusted risk factors are independently associated with an increased risk of ischaemic stroke, transient ischaemic stroke and systemic embolism in the ETNA-AF-Europe registry

27 August 2021

This platform is supported by

logo Novo Nordisk